Quality of Life-Guided Transfusion in Refractory MDS or AML — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Quality of Life-Guided Transfusion in Refractory MDS or AML — Stella

Recruiting

Back to MDS trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

CHU de Nice, Nice

Key details

Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment target

~52 participants

Started

February 2026

Primary completion

February 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov